MA33823B1 - Polythérapie pour bronchopneumopathie chronique obstructive (copd) - Google Patents
Polythérapie pour bronchopneumopathie chronique obstructive (copd)Info
- Publication number
- MA33823B1 MA33823B1 MA34966A MA34966A MA33823B1 MA 33823 B1 MA33823 B1 MA 33823B1 MA 34966 A MA34966 A MA 34966A MA 34966 A MA34966 A MA 34966A MA 33823 B1 MA33823 B1 MA 33823B1
- Authority
- MA
- Morocco
- Prior art keywords
- preparation
- copd
- formoterol
- combined treatment
- glycopyrronium bromide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/009—Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B3/00—Packaging plastic material, semiliquids, liquids or mixed solids and liquids, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
- B65B3/04—Methods of, or means for, filling the material into the containers or receptacles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
- B65B31/003—Adding propellants in fluid form to aerosol containers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B7/00—Closing containers or receptacles after filling
- B65B7/16—Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons
- B65B7/28—Closing semi-rigid or rigid containers or receptacles not deformed by, or not taking-up shape of, contents, e.g. boxes or cartons by applying separate preformed closures, e.g. lids, covers
- B65B7/2842—Securing closures on containers
- B65B7/285—Securing closures on containers by deformation of the closure
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Dispersion Chemistry (AREA)
- Mechanical Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
Abstract
L'invention concerne une préparation aérosol conçue pour être administrée à des patients atteints de bronchopneumopathie chronique obstructive au moyen d'un aérosol doseur sous pression (pmdi), laquelle préparation comprend du bromure de glycopyrronium combinà du formotérol. La préparation comprend également un propulseur hfa, un co-solvant et une quantité d'acide inorganique suffisante pour stabiliser à la fois les composé de bromure de glycopyrronium et de formotérol. éventuellement, la préparation comprend également du dipropionate de béclométasone.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09180671 | 2009-12-23 | ||
PCT/EP2010/070479 WO2011076843A2 (fr) | 2009-12-23 | 2010-12-22 | Polythérapie pour bronchopneumopathie chronique obstructive (copd) |
Publications (1)
Publication Number | Publication Date |
---|---|
MA33823B1 true MA33823B1 (fr) | 2012-12-03 |
Family
ID=42107420
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA34966A MA33823B1 (fr) | 2009-12-23 | 2012-06-14 | Polythérapie pour bronchopneumopathie chronique obstructive (copd) |
Country Status (39)
Country | Link |
---|---|
US (3) | US20110150782A1 (fr) |
EP (1) | EP2515855B3 (fr) |
JP (2) | JP5914354B2 (fr) |
KR (2) | KR20170040392A (fr) |
CN (2) | CN104055765B (fr) |
AR (2) | AR079726A1 (fr) |
AU (3) | AU2010334859A1 (fr) |
BR (1) | BR112012015337B8 (fr) |
CA (1) | CA2785321C (fr) |
CL (1) | CL2012001705A1 (fr) |
CO (1) | CO6541628A2 (fr) |
CY (2) | CY1115116T1 (fr) |
DK (1) | DK2515855T6 (fr) |
EA (2) | EA021917B1 (fr) |
ES (1) | ES2468840T7 (fr) |
FI (1) | FI2515855T6 (fr) |
GE (1) | GEP20156311B (fr) |
HK (2) | HK1174566A1 (fr) |
HR (1) | HRP20140582T4 (fr) |
HU (1) | HUS1800001I1 (fr) |
IL (1) | IL260932B (fr) |
LT (1) | LTC2515855I2 (fr) |
LU (1) | LUC00060I2 (fr) |
MA (1) | MA33823B1 (fr) |
MX (1) | MX2012006878A (fr) |
MY (1) | MY156949A (fr) |
NL (1) | NL300923I2 (fr) |
NZ (1) | NZ600790A (fr) |
PE (2) | PE20121396A1 (fr) |
PL (1) | PL2515855T6 (fr) |
PT (1) | PT2515855E (fr) |
RS (1) | RS53391B2 (fr) |
SG (1) | SG181868A1 (fr) |
SI (1) | SI2515855T1 (fr) |
TN (1) | TN2012000269A1 (fr) |
TW (1) | TWI495468B (fr) |
UA (1) | UA113832C2 (fr) |
WO (1) | WO2011076843A2 (fr) |
ZA (1) | ZA201204615B (fr) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA021604B1 (ru) | 2009-12-23 | 2015-07-30 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Аэрозольная композиция для лечения астмы и copd |
WO2011076843A2 (fr) * | 2009-12-23 | 2011-06-30 | Chiesi Farmaceutici S.P.A. | Polythérapie pour bronchopneumopathie chronique obstructive (copd) |
WO2011076841A2 (fr) * | 2009-12-23 | 2011-06-30 | Chiesi Farmaceutici S.P.A. | Polythérapie destinée à la bronchopneumopathie chronique obstructive |
KR20140012989A (ko) * | 2011-02-17 | 2014-02-04 | 시플라 리미티드 | 글리코피롤레이트 및 베타2-효능제의 조합 |
BR112014008114B1 (pt) * | 2011-10-11 | 2022-07-26 | Chiesi Farmaceutici S.P.A. | Micropartículas cristalinas, formulação farmacêutica, inalador dosimetrado pressurizado, formulação farmacêutica, processo para preparar microparticulas cristalinas e uso de micropartículas cristalinas |
WO2014064410A2 (fr) * | 2012-10-23 | 2014-05-01 | Cipla Limited | Composition pharmaceutique |
GEP20186853B (en) | 2013-07-11 | 2018-05-25 | Chiesi Farma Spa | Dry powder formulation comprising anticholinergic, corticosteroid and beta-adrenergic for administration by inhalation |
PL3089735T3 (pl) * | 2013-12-30 | 2018-12-31 | Chiesi Farmaceutici S.P.A. | Trwała ciśnieniowa kompozycja roztworu aerozolowego kombinacji bromku glikopironium i formoterolu |
UA117846C2 (uk) * | 2013-12-30 | 2018-10-10 | К'Єзі Фармачеутічі С.П.А. | Стабільна композиція аерозольного розчину під тиском комбінації глікопіроніюброміду та формотеролу |
US9622483B2 (en) | 2014-02-19 | 2017-04-18 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
US11039620B2 (en) | 2014-02-19 | 2021-06-22 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
US11039621B2 (en) | 2014-02-19 | 2021-06-22 | Corning Incorporated | Antimicrobial glass compositions, glasses and polymeric articles incorporating the same |
US9554992B2 (en) * | 2014-06-09 | 2017-01-31 | Chiesi Farmaceutici S.P.A. | Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic |
GB201416909D0 (en) * | 2014-09-25 | 2014-11-12 | Prosonix Ltd | Method of forming concentrated solution |
US20160310410A1 (en) | 2015-04-24 | 2016-10-27 | Glenmark Specialty S.A. | Pharmaceutical compositions comprising arformoterol and glycopyrronium |
LT3377108T (lt) | 2015-11-16 | 2020-07-10 | Chiesi Farmaceutici S.P.A. | Inhaliacinių miltelių kompozicijos, apimančios anticholinerginį agentą, kortikosteroidą ir beta adrenerginį agentą, paruošimo būdas |
GB2545025A (en) * | 2015-12-04 | 2017-06-07 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
EP3436115B1 (fr) | 2016-03-31 | 2021-07-28 | Chiesi Farmaceutici S.p.A. | Dispositif d'inhalation d'aérosol |
US10098837B2 (en) | 2016-07-28 | 2018-10-16 | Chiesi Farmaceutici S.P.A. | Combination therapy for COPD |
US10792256B2 (en) * | 2016-09-19 | 2020-10-06 | Mexichem Fluor S.A. De C.V. | Pharmaceutical composition |
JP6781831B2 (ja) * | 2016-09-19 | 2020-11-04 | メキシケム フロー エセ・ア・デ・セ・ヴェ | 医薬組成物 |
CN114272238A (zh) | 2016-09-19 | 2022-04-05 | 墨西哥氟石股份公司 | 药物组合物 |
RU2741427C1 (ru) * | 2017-05-11 | 2021-01-26 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Способ получения состава сухого порошка, содержащего антихолинергическое средство, кортикостероид и бета-адренергетик |
MA48621A (fr) * | 2017-05-11 | 2021-04-28 | Chiesi Farm Spa | Procédé de préparation d'une formulation de poudre sèche contenant un anticholinergique, un corticostéroïde et un bêta-adrénergique |
IL293328A (en) | 2019-12-02 | 2022-07-01 | Chiesi Farm Spa | Stainless steel canister for pressurized metered dose inhalers |
EP4188327A1 (fr) | 2020-07-31 | 2023-06-07 | Chemo Research, S.L. | Polythérapie destinée à une administration par inhalation |
AU2021356146A1 (en) | 2020-10-09 | 2023-05-04 | Chiesi Farmaceutici S.P.A. | A pharmaceutical formulation for pressurised metered dose inhaler |
WO2023227783A1 (fr) | 2022-05-27 | 2023-11-30 | Chiesi Farmaceutici S.P.A. | Formulation pharmaceutique pour aérosol-doseur sous pression |
WO2023227782A1 (fr) | 2022-05-27 | 2023-11-30 | Chiesi Farmaceutici S.P.A. | Formulation pharmaceutique pour aérosol-doseur pressurisé |
WO2023227781A1 (fr) | 2022-05-27 | 2023-11-30 | Chiesi Farmaceutici S.P.A. | Formulation pharmaceutique pour aérosol-doseur sous pression |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2956062A (en) | 1959-02-26 | 1960-10-11 | Robins Co Inc A H | Esters of amino alcohols |
PL177078B1 (pl) | 1992-12-09 | 1999-09-30 | Boehringer Ingelheim Pharma | Preparaty roztworów aerozolowych |
CN1158996C (zh) | 1998-07-24 | 2004-07-28 | 杰格研究股份公司 | 药用气溶胶制剂 |
CA2338680C (fr) * | 1998-08-04 | 2008-10-14 | Jago Research Ag | Formulations d'aerosol a usage medical |
US20060171899A1 (en) * | 1998-12-10 | 2006-08-03 | Akwete Adjei | Water-stabilized aerosol formulation system and method of making |
IT1317720B1 (it) | 2000-01-07 | 2003-07-15 | Chiesi Farma Spa | Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani. |
GB0008660D0 (en) | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
US20060257324A1 (en) * | 2000-05-22 | 2006-11-16 | Chiesi Farmaceutici S.P.A. | Pharmaceutical solution formulations for pressurised metered dose inhalers |
AU2000250701B2 (en) * | 2000-05-22 | 2004-07-01 | Chiesi Farmaceutici S.P.A. | Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
RU2294737C2 (ru) | 2001-03-30 | 2007-03-10 | Яготек Аг | Медицинские аэрозольные составы |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
EP1321159A1 (fr) | 2001-12-21 | 2003-06-25 | CHIESI FARMACEUTICI S.p.A. | Dispositif d'actionnement pour inhalateur doseur pressurisé avec orifices percés par laser |
ES2745064T3 (es) | 2002-03-01 | 2020-02-27 | Chiesi Farm Spa | Formulación superfina de formoterol |
WO2004054580A1 (fr) | 2002-12-16 | 2004-07-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Formulations de solutions aux hfc contenant du tiotropium |
AR041873A1 (es) * | 2003-10-30 | 2005-06-01 | Pablo Cassara Srl Lab | Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante |
CA2551780C (fr) | 2004-02-06 | 2013-02-26 | Meda Pharma Gmbh & Co. Kg | Combinaison d'anticholinergiques et de glucocorticoides pour le traitement prolonge de l'asthme et des broncho-pneumopathies chroniques obstructives |
DE602005007708D1 (de) * | 2004-02-06 | 2008-08-07 | Meda Pharma Gmbh & Co Kg | Neue kombination von anticholinergen und beta mimetika zur behanldung von atemwegserkrankungen |
GB0410399D0 (en) | 2004-05-10 | 2004-06-16 | Arakis Ltd | The treatment of respiratory disease |
GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
EP1616567A1 (fr) | 2004-07-16 | 2006-01-18 | Boehringer Ingelheim Pharma GmbH & Co.KG | Médicaments comprenant des inhibiteurs de PDE-IV et des sels de glycopyrolate pour l'inhalation |
GB0505545D0 (en) | 2005-03-17 | 2005-04-27 | Glaxo Group Ltd | Inhalation devices |
EP2484382A1 (fr) | 2005-03-30 | 2012-08-08 | Schering Corporation | Médicament à base d'un inhibiteur de la phosphodiestérase IV sous une forme adaptée à l'inhalation |
GB0523653D0 (en) | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
BRPI0614436A2 (pt) | 2005-08-01 | 2011-03-29 | Astrazeneca Ab | válvula inaladora |
GB0523656D0 (en) | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
GB0523654D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
GB0523655D0 (en) | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
CA2824075C (fr) | 2005-12-21 | 2015-04-28 | Joachim Maus | Combinaison de r, r-glycopyrrolate, formoterole et d'un glucocorticoide pour le traitement de maladies inflammatoires |
GB0613161D0 (en) | 2006-06-30 | 2006-08-09 | Novartis Ag | Organic Compounds |
EP1894568A1 (fr) | 2006-08-31 | 2008-03-05 | Novartis AG | Composées pharmaceutiques destinées au traitement des maladies inflammatoires ou obstructives des bronches |
EP3415127B1 (fr) | 2007-10-18 | 2023-12-20 | Rose U, LLC | Formulations topiques de glycopyrrolate et une lingette en contenant |
EP2440196A4 (fr) * | 2009-06-09 | 2013-01-02 | Elevation Pharmaceuticals Inc | Traitement d'une maladie pulmonaire obstructive chronique par administration de bêta 2 agoniste nébulisé ou d'une combinaison de bêta 2 agoniste nébulisé et d'anticholinergique |
BR112012015335B1 (pt) * | 2009-12-23 | 2021-05-18 | Chiesi Farmaceutici S.P.A. | formulação de aerossol para doença pulmonar obstrutiva crõnica |
EA021604B1 (ru) * | 2009-12-23 | 2015-07-30 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Аэрозольная композиция для лечения астмы и copd |
WO2011076843A2 (fr) * | 2009-12-23 | 2011-06-30 | Chiesi Farmaceutici S.P.A. | Polythérapie pour bronchopneumopathie chronique obstructive (copd) |
WO2011076841A2 (fr) * | 2009-12-23 | 2011-06-30 | Chiesi Farmaceutici S.P.A. | Polythérapie destinée à la bronchopneumopathie chronique obstructive |
GEP20186853B (en) * | 2013-07-11 | 2018-05-25 | Chiesi Farma Spa | Dry powder formulation comprising anticholinergic, corticosteroid and beta-adrenergic for administration by inhalation |
UA117846C2 (uk) | 2013-12-30 | 2018-10-10 | К'Єзі Фармачеутічі С.П.А. | Стабільна композиція аерозольного розчину під тиском комбінації глікопіроніюброміду та формотеролу |
PL3089735T3 (pl) | 2013-12-30 | 2018-12-31 | Chiesi Farmaceutici S.P.A. | Trwała ciśnieniowa kompozycja roztworu aerozolowego kombinacji bromku glikopironium i formoterolu |
US9554992B2 (en) * | 2014-06-09 | 2017-01-31 | Chiesi Farmaceutici S.P.A. | Inhalation particles comprising a combination of an anticholinergic, a corticosteroid and a beta-adrenergic |
US10098837B2 (en) * | 2016-07-28 | 2018-10-16 | Chiesi Farmaceutici S.P.A. | Combination therapy for COPD |
-
2010
- 2010-12-22 WO PCT/EP2010/070479 patent/WO2011076843A2/fr active Application Filing
- 2010-12-22 SI SI201030654T patent/SI2515855T1/sl unknown
- 2010-12-22 EP EP10799030.1A patent/EP2515855B3/fr active Active
- 2010-12-22 PE PE2012000865A patent/PE20121396A1/es not_active Application Discontinuation
- 2010-12-22 CN CN201410289445.6A patent/CN104055765B/zh active Active
- 2010-12-22 PE PE2016000787A patent/PE20160853A1/es unknown
- 2010-12-22 GE GEAP201012756A patent/GEP20156311B/en unknown
- 2010-12-22 JP JP2012545323A patent/JP5914354B2/ja active Active
- 2010-12-22 SG SG2012046157A patent/SG181868A1/en unknown
- 2010-12-22 KR KR1020177009412A patent/KR20170040392A/ko active Search and Examination
- 2010-12-22 ES ES10799030T patent/ES2468840T7/es active Active
- 2010-12-22 BR BR112012015337A patent/BR112012015337B8/pt active IP Right Grant
- 2010-12-22 EA EA201290375A patent/EA021917B1/ru active Protection Beyond IP Right Term
- 2010-12-22 MX MX2012006878A patent/MX2012006878A/es active IP Right Grant
- 2010-12-22 MY MYPI2012002844A patent/MY156949A/en unknown
- 2010-12-22 EA EA201590179A patent/EA027778B1/ru active Protection Beyond IP Right Term
- 2010-12-22 PL PL10799030.1T patent/PL2515855T6/pl unknown
- 2010-12-22 UA UAA201207626A patent/UA113832C2/uk unknown
- 2010-12-22 DK DK10799030.1T patent/DK2515855T6/da active
- 2010-12-22 TW TW099145166A patent/TWI495468B/zh active
- 2010-12-22 AU AU2010334859A patent/AU2010334859A1/en not_active Abandoned
- 2010-12-22 NZ NZ600790A patent/NZ600790A/en unknown
- 2010-12-22 CN CN201080058048.8A patent/CN102665679B/zh active Active
- 2010-12-22 RS RS20140338A patent/RS53391B2/sr unknown
- 2010-12-22 PT PT107990301T patent/PT2515855E/pt unknown
- 2010-12-22 AR ARP100104922A patent/AR079726A1/es not_active Application Discontinuation
- 2010-12-22 CA CA2785321A patent/CA2785321C/fr active Active
- 2010-12-22 KR KR1020127015996A patent/KR101757951B1/ko active IP Right Grant
- 2010-12-23 US US12/977,159 patent/US20110150782A1/en not_active Abandoned
-
2012
- 2012-05-29 TN TNP2012000269A patent/TN2012000269A1/en unknown
- 2012-06-01 CO CO12092198A patent/CO6541628A2/es unknown
- 2012-06-14 MA MA34966A patent/MA33823B1/fr unknown
- 2012-06-21 CL CL2012001705A patent/CL2012001705A1/es unknown
- 2012-06-21 ZA ZA2012/04615A patent/ZA201204615B/en unknown
-
2013
- 2013-02-15 HK HK13101936.0A patent/HK1174566A1/xx unknown
-
2014
- 2014-05-29 CY CY20141100382T patent/CY1115116T1/el unknown
- 2014-06-23 HR HRP20140582TT patent/HRP20140582T4/hr unknown
- 2014-10-23 HK HK14110591A patent/HK1197036A1/xx unknown
-
2015
- 2015-07-29 US US14/812,190 patent/US10159645B2/en active Active
-
2016
- 2016-04-04 JP JP2016075136A patent/JP6283388B2/ja active Active
- 2016-09-27 AU AU2016234895A patent/AU2016234895B2/en active Active
-
2017
- 2017-12-22 CY CY2017047C patent/CY2017047I2/el unknown
- 2017-12-29 FI FIEP10799030.1T patent/FI2515855T6/fi active
-
2018
- 2018-01-05 HU HUS1800001C patent/HUS1800001I1/hu unknown
- 2018-01-10 LU LU00060C patent/LUC00060I2/fr unknown
- 2018-01-11 LT LTPA2018001C patent/LTC2515855I2/lt unknown
- 2018-01-12 NL NL300923C patent/NL300923I2/en unknown
- 2018-04-30 AU AU2018202998A patent/AU2018202998A1/en not_active Abandoned
- 2018-08-01 IL IL260932A patent/IL260932B/en active IP Right Grant
- 2018-10-16 US US16/161,427 patent/US11389401B2/en active Active
-
2019
- 2019-08-02 AR ARP190102199A patent/AR115897A2/es not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MA33823B1 (fr) | Polythérapie pour bronchopneumopathie chronique obstructive (copd) | |
WO2011076841A3 (fr) | Polythérapie destinée à la bronchopneumopathie chronique obstructive | |
ME00077B (fr) | Preparation superfine de formoterol | |
AR101593A2 (es) | Formulación superfina de formoterol | |
HRP20130835T1 (hr) | Farmaceutske formulacije otopine za davanje kao stlaäśeni inhalat u inhalatoru | |
WO2013021199A3 (fr) | Compositions pharmaceutiques | |
MA33821B1 (fr) | Préparation aérosol pour copd (bronchopneumathie chronique obstructive) | |
RU2010108640A (ru) | Новая комбинация терапевтических агентов | |
JP2010132695A5 (fr) | ||
CA2550841A1 (fr) | Nouvelle combinaison d'anticholinergique et de beta-mimetiques pour le traitement de maladies respiratoires | |
NO20051956L (no) | Salmeterol superfin formulering | |
JP2013542940A5 (fr) | ||
RU2008129600A (ru) | Комбинация и фармацевтический препарат для лечения воспалительных заболеваний | |
RU2013106866A (ru) | Фармацевтические композиции | |
WO2008151235A3 (fr) | Procédés et compositions pour administrer des médicaments aux poumons | |
PE20091672A1 (es) | Nueva dosificacion y formulacion | |
WO2007137204A3 (fr) | Méthodes de distribution d'un agoniste bêta2 pour induire une bronchodilatation et formulations utilisées dans ces procédés | |
JP2019528316A5 (fr) | ||
MX2023003754A (es) | Formulacion farmaceutica para inhalador presurizado de dosis medidas. | |
CN102695496A (zh) | 用于copd的气雾剂制剂 | |
JO3024B1 (ar) | صيغ أيروسول صيدلانية من الفرموتيرول وبكلوميتازون داي بروبيونات | |
Plaunt et al. | Structure Dependent PK Profiles Of Alkyl Ester Treprostinil Prodrugs (TPD) Administrated Via Metered Dose Inhaler To Rats | |
TH127043B (th) | ผลิตภัณฑ์รวมสำหรับบำบัด copd |